Tirzepatide is a medication that targets two hormones involved in appetite regulation and metabolic function: GLP-1 GIP Together, these hormones help: reduce appetite, slow digestion, improve fullness, stabilize blood sugar, reduce cravings, and naturally lower calorie intake
The exact timeline depends on several factors, including the patients starting weight, lifestyle choices, and response to treatment
Figure S9
The costs of the treatment may vary depending on factors such as the treatment area and the amount of product needed
If you find your vision changes, you should stop taking the medication and contact a medical professional as soon as possible
Existing biomarkers, such as the insulin-like growth factor-binding protein 4 (IBP4) to sex hormone-binding globulin (SHBG) ratio, offer modest predictive performance and are restricted to mid-gestation use (1820 weeks), limiting their utility for timely intervention